These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9817388)

  • 1. The pathogenesis of benign prostatic hyperplasia: a proposed hypothesis and critical evaluation.
    Grayhack JT; Kozlowski JM; Lee C
    J Urol; 1998 Dec; 160(6 Pt 2):2375-80. PubMed ID: 9817388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pigment epithelium-derived factor, a human testis epididymis secretory product, promotes human prostate stromal cell growth in culture.
    Grayhack JT; Smith ND; Ilio K; Wambi C; Kasjanski R; Crawford SE; Doll JA; Wang Z; Lee C; Kozlowski JM
    J Urol; 2004 Jan; 171(1):434-8. PubMed ID: 14665949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of testicular irradiation on established BPH in the dog: evidence of a non-steroidal testicular factor for BPH maintenance.
    Grayhack JT; Lee C; Brand W
    J Urol; 1985 Dec; 134(6):1276-81. PubMed ID: 2414473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic action of steroids and spermatocele fluid on in vitro proliferation of prostate stroma.
    Grayhack JT; Sensibar JA; Ilio KY; Kasjanski RZ; Kozlowski JM; Lee C
    J Urol; 1998 Jun; 159(6):2202-9. PubMed ID: 9598570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta.
    Huang X; Lee C
    Front Biosci; 2003 Sep; 8():s740-9. PubMed ID: 12957826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign prostatic hyperplasia and growth factors.
    Lawson RK
    Urologe A; 1990 Jan; 29(1):5-7. PubMed ID: 1690485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and experimental studies of benign prostatic hyperplasia.
    Coffey DS; Walsh PC
    Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture.
    Boudon C; Rodier G; Lechevallier E; Mottet N; Barenton B; Sultan C
    J Clin Endocrinol Metab; 1996 Feb; 81(2):612-7. PubMed ID: 8636277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The requirement of the testis in establishing the sensitivity of the canine prostate to develop benign prostatic hyperplasia.
    Juniewicz PE; Berry SJ; Coffey DS; Strandberg JD; Ewing LL
    J Urol; 1994 Sep; 152(3):996-1001. PubMed ID: 7519686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog.
    Crescioli C; Ferruzzi P; Caporali A; Mancina R; Comerci A; Muratori M; Scaltriti M; Vannelli GB; Smiroldo S; Mariani R; Villari D; Bettuzzi S; Serio M; Adorini L; Maggi M
    Endocrinology; 2003 Jul; 144(7):3046-57. PubMed ID: 12810561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin and prostatic function.
    Nicholson HD; Jenkin L
    Adv Exp Med Biol; 1995; 395():529-38. PubMed ID: 8714010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.
    Fibbi B; Penna G; Morelli A; Adorini L; Maggi M
    Int J Androl; 2010 Jun; 33(3):475-88. PubMed ID: 19508330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia.
    Prins GS; Jung MH; Vellanoweth RL; Chatterjee B; Roy AK
    Dev Genet; 1996; 18(2):99-106. PubMed ID: 8934871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The origin and development of benign prostatic hyperplasia. An age-dependent process.
    Oesterling JE
    J Androl; 1991; 12(6):348-55. PubMed ID: 1722790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.
    Ho CK; Nanda J; Chapman KE; Habib FK
    J Endocrinol; 2008 Jun; 197(3):483-91. PubMed ID: 18492814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of spermatocele fluid on growth of human prostatic cells in culture.
    Sutkowski DM; Kasjanski RZ; Sensibar JA; Ney KG; Lim DJ; Kozlowski JM; Lee C; Grayhack JT
    J Androl; 1993; 14(4):233-9. PubMed ID: 8226302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Why does the prostate grow? Possible role of growth factors for development of benign prostatic hyperplasia].
    Tørring N; Nexø E
    Ugeskr Laeger; 1997 May; 159(19):2833-5. PubMed ID: 9190708
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
    Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
    J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.